Adicet Bio, Inc. — Director's Dealing 2021

May 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-04-30

Reporting Person: Sanna Bastiano (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-30	Stock Option (Right to Buy)	$15.93	A	18500	Acquired	2031-04-29	Common Stock (18500)	Direct
2021-04-30	Stock Option (Right to Buy)	$15.93	A	1172	Acquired	2031-04-29	Common Stock (1172)	Direct

Footnotes

F1: These shares shall vest in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

F2: These shares shall vest in thirty-six (36) equal monthly installments beginning December 1, 2020.